{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T05:40:47Z","timestamp":1710222047372},"reference-count":10,"publisher":"BMJ","issue":"6785","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMJ"],"published-print":{"date-parts":[[1991,5,11]]},"DOI":"10.1136\/bmj.302.6785.1149","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T12:16:37Z","timestamp":1238415397000},"page":"1149-1149","source":"Crossref","is-referenced-by-count":10,"title":["Pituitary growth hormone and Creutzfeldt-Jakob disease."],"prefix":"10.1136","volume":"302","author":[{"given":"M E","family":"Macario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Vaisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Buescu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V","family":"Moura Neto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H M","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Chagas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","first-page":"824","article-title":"and Cretitzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom","volume":"302","author":"Buchanan, C.R.; Preece, M.A.; Mortality, MSlimer R.D.G.; neoplasia","year":"1991","unstructured":"Buchanan CR, Preece MA, MSlimer RDG. Mortality, neoplasia, and Cretitzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. BM_7 1991;302:824-8. (6 April.)"},{"key":"ref_2","first-page":"1243","article-title":"Microheterogeneity of' tubhLlin proteins in neuronal and glial cells from the mouse brain culture","volume":"2","author":"Neto \\INI, MIallat M, Jeantet C","year":"1983","unstructured":"Neto \\INI, MIallat M, Jeantet C, et al. Microheterogeneity of' tubhLlin proteins in neuronal and glial cells from the mouse brain culture. EMRBOJ 1983;2:1243-8.","journal-title":"EMRBOJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198607313150502","article-title":"Abnormal proteins in the cerebrospinal fluid of patients with CretitzfeldtJakob disease","volume":"315","author":"Harrington, M.G.; MIerril, C.R.; Asher, D.I.N.M.; Gajdusek, D.C.","year":"1986","unstructured":"Harrington MG, MIerril CR, Asher DINM, Gajdusek DC. Abnormal proteins in the cerebrospinal fluid of patients with CretitzfeldtJakob disease. N EnglIJMed 1986;315:279-83.","journal-title":"N EnglIJMed"},{"key":"ref_4","first-page":"1128","article-title":"A new case of CreutzfeldtJakob disease associated with huiman growth hormone therapy in New Zealand","volume":"38","author":"Croxson, M.; Brown, P.; Svnck, B.","year":"1988","unstructured":"Croxson M, Brown P, Svnck B, et al. A new case of CreutzfeldtJakob disease associated with huiman growth hormone therapy in New Zealand. i'eurologc 1988;38:1128-30.","journal-title":"i'eurologc"},{"key":"ref_5","first-page":"546","article-title":"Chemoprophylaxis for Haemophiltus Influenizae type b","volume":"302","author":"KAy', Cartwright; NT, Begg; D, Hull","year":"1991","unstructured":"Cartwright KAy', Begg NT, Hull D. Chemoprophylaxis for Haemophiltus Influenizae type b. BM7 1991;302:546-7. t9 M\\larch.:)"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0278-2316(88)90002-3","article-title":"Prevention of infections caused by Haemophilus influenzae","volume":"7","author":"Kaplan, S.","year":"1988","unstructured":"Kaplan S. Prevention of infections caused by Haemophilus influenzae. InPectious Diseases Newsletter 1988;7:51-3.","journal-title":"InPectious Diseases Newsletter"},{"key":"ref_7","first-page":"2","article-title":"Chemoprophvlaxis for secondary Haemophilus influenzae type b disease","volume":"1","author":"Cartwright, K.A.V.; NTr, Begg; Hull, D.","year":"1991","unstructured":"Cartwright KAV, Begg NTr, Hull D. Chemoprophvlaxis for secondary Haemophilus influenzae type b disease. CDR Revie.w 1991;1:R2-6.","journal-title":"CDR Revie.w"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/clinids\/12.4.708","article-title":"Life threatening Haemophiltis infltuenzae infections in Scandinavia: a fivecountry analysis of the incidence and the main clinical and bacteriological characteristics. Rez'","volume":"12","author":"Peltola, H.; Rod, T.D.; Jonsdottir, K.","year":"1990","unstructured":"Peltola H, Rod TD, Jonsdottir K, et al. Life threatening Haemophiltis infltuenzae infections in Scandinavia: a fivecountry analysis of the incidence and the main clinical and bacteriological characteristics. Rez' Infeci Di's 1990;12:708-15.","journal-title":"Infeci Di's"},{"key":"ref_9","first-page":"397","article-title":"Haemophilus influenzae type b disease in a day care center: eradication of carrier state by rifampin","volume-title":"Pediatrics","volume":"63","author":"Granoff, D.M.; Gilsdorf, J.; Gessert, C.","year":"1979","unstructured":"Granoff DM, Gilsdorf J, Gessert C, et al. Haemophilus influenzae type b disease in a day care center: eradication of carrier state by rifampin. Pediatrics 1979;63:397-401."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1542\/peds.66.1.5","article-title":"Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b","volume":"66","author":"Shapiro, E.D.; Wald, E.R.","year":"1980","unstructured":"Shapiro ED, Wald ER. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b. Pediatrics 1980;66:5-8.","journal-title":"Pediatrics"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.302.6785.1149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T05:15:10Z","timestamp":1710220510000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.302.6785.1149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1991,5,11]]},"references-count":10,"journal-issue":{"issue":"6785","published-print":{"date-parts":[[1991,5,11]]}},"URL":"https:\/\/doi.org\/10.1136\/bmj.302.6785.1149","relation":{},"ISSN":["0959-8138","1468-5833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1468-5833","type":"electronic"}],"subject":[],"published":{"date-parts":[[1991,5,11]]}}}